Comparative pharmacokinetics and pharmacodinamics of noopept, its activity metabolite cycloprolylglycine and piracetam
While studing of experimental pharmacokinetics of the peptide analogues piracetam noopept - N-phenylacetyl-L-prolyl-glycine ethyl ester, was found the active metabolite that identificated as cyclo-L-prolylglycine (CPG). At that thime CPG was detected as the endogenous compound in plasma and brain. I...
Saved in:
Main Authors: | Svetlana Boyko (Author), Ksenia Kolyasnikova (Author), Vladimir Zherdev (Author) |
---|---|
Format: | Book |
Published: |
LLC "Publisher OKI",
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative study of pharmacokinetics and enzymatic resistance of the neuroprotective mean GZK-111 and noopept in rats
by: S. S. Boyko, et al.
Published: (2022) -
The Study of [3H]-Cycloprolylglycine Pharmacokinetics in Rat Blood
by: G. I. Kovalev, et al.
Published: (2019) -
The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c mice
by: A. A. Abdullina, et al.
Published: (2020) -
Neuroprotective effect of L-cycloprolylglycine on models neuronal cells damage in vitro
by: S. V. Nikolaev, et al.
Published: (2017) -
The relationship between the content of the potential psychopharmacological agent cyclo-L-prolylglycine in the brain of experimental animals and its antihypoxic effect
by: V. P. Zherdev, et al.
Published: (2020)